Search research articles
Contact Us
Filters
Showing results (151-160 of 180) with videos related to
Page
of 18
Sort By:
Medical Image Analysis
|
September 29, 2004
Brain morphometry using 3D moment invariants
J-F Mangin, F Poupon, E Duchesnay, et al.
British Journal of Cancer
|
August 1, 1993
Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases
L H Ramirez, J N Munck, C Bognel, et al.
Journal of the National Cancer Institute
|
December 15, 1993
Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates
M F Poupon, F Arvelo, A F Goguel, et al.
Journal of the National Cancer Institute
|
September 25, 1998
Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment
L Miccoli, F Poirson-Bichat, F Sureau, et al.
Biochemical Pharmacology
|
August 4, 1992
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
C Cuvier, L Roblot-Treupel, J M Millot, et al.
Cancer Research
|
May 1, 1991
Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363
A Pierré, L Kraus-Berthier, G Atassi, et al.
Cancer Research
|
August 15, 1997
Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines
V Dangles, F Féménia, V Lainé, et al.
Cancer Letters
|
September 29, 1998
Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy
Y Canitrot, F Bichat, S P Cole, et al.
Journal of Neuro-Oncology
|
June 20, 2003
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
Stéphane Oudard, Antoine Carpentier, Eugeniu Banu, et al.
Experimental Cell Research
|
August 2, 2001
Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors
D Decaudin, A Beurdeley-Thomas, F Nemati, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 180) with videos related to
Sort By:
Page
of 18
Medical Image Analysis
|
September 29, 2004
Brain morphometry using 3D moment invariants
J-F Mangin, F Poupon, E Duchesnay, et al.
British Journal of Cancer
|
August 1, 1993
Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases
L H Ramirez, J N Munck, C Bognel, et al.
Journal of the National Cancer Institute
|
December 15, 1993
Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates
M F Poupon, F Arvelo, A F Goguel, et al.
Journal of the National Cancer Institute
|
September 25, 1998
Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment
L Miccoli, F Poirson-Bichat, F Sureau, et al.
Biochemical Pharmacology
|
August 4, 1992
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
C Cuvier, L Roblot-Treupel, J M Millot, et al.
Cancer Research
|
May 1, 1991
Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363
A Pierré, L Kraus-Berthier, G Atassi, et al.
Cancer Research
|
August 15, 1997
Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines
V Dangles, F Féménia, V Lainé, et al.
Cancer Letters
|
September 29, 1998
Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy
Y Canitrot, F Bichat, S P Cole, et al.
Journal of Neuro-Oncology
|
June 20, 2003
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
Stéphane Oudard, Antoine Carpentier, Eugeniu Banu, et al.
Experimental Cell Research
|
August 2, 2001
Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors
D Decaudin, A Beurdeley-Thomas, F Nemati, et al.
Page
of 18